Abbvie Inc (NYSE:ABBV)

75.04
Delayed Data
As of Apr 02
 +1.62 / +2.21%
Today’s Change
62.55
Today|||52-Week Range
97.86
-15.25%
Year-to-Date
4 Stocks You'll Be Glad You Bought at These Prices
Mar 31 / MotleyFool.com - Paid Partner Content
3 Dirt-Cheap Healthcare Stocks to Buy Right Now
Mar 27 / MotleyFool.com - Paid Partner Content
4 Reasons Drug Stocks Are a Buy Right Now
Mar 30 / MotleyFool.com - Paid Partner Content
3 Big Pharma Stocks Plunging the Most During the Coronavirus Stock Market Crash: Are They Buys?
Mar 26 / MotleyFool.com - Paid Partner Content
These companies are racing to roll out COVID-19 treatments
Mar 30 / CNN.com - Paid Partner Content
3 Reasons Pharma Stocks Are a Buy Right Now
Mar 25 / MotleyFool.com - Paid Partner Content
Have $1,000 to Invest? 3 Great High-Yield Dividend Stocks to Buy Right Now
Mar 29 / MotleyFool.com - Paid Partner Content
Better Buy: AbbVie vs. Biogen
Mar 24 / MotleyFool.com - Paid Partner Content
2 Dividend Stocks Trading at Dirt-Cheap Prices
Mar 27 / MotleyFool.com - Paid Partner Content
These 3 Dividend Stocks Are Now Yielding Up to 20%
Mar 23 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close73.42
Today’s open72.74
Day’s range71.46 - 75.49
Volume8,077,758
Average volume (3 months)10,641,307
Market cap$108.8B
Data as of 4:00pm ET, 04/02/2020

Growth & Valuation

Earnings growth (last year)+44.28%
Earnings growth (this year)+6.36%
Earnings growth (next 5 years)+14.00%
Revenue growth (last year)+1.57%
P/E ratio14.2
Price/Sales3.95
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk-0.44-0.74%
SNYSanofi+0.56+1.31%
AZNAstraZeneca0.000.00%
GSKGlaxoSmithKline+0.50+1.34%
Data as of 4:00pm ET, 04/02/2020

Financials

Next reporting dateApril 23, 2020
EPS forecast (this quarter)$2.24
Annual revenue (last year)$33.3B
Annual profit (last year)$7.8B
Net profit margin23.57%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
North Chicago, Illinois

Forecasts